ロード中...
Enhanced Early Innate and T Cell-mediated Responses in Subjects Immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909)
NuThrax(™) (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant) (AV7909) is in development. Samples obtained in a Phase Ib clinical trial were tested to confirm biomarkers of innate immunity and evaluate effects of CPG 7909 (PF-03512676) on adaptive immunity. Subjects received two intramuscular doses o...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4133324/ https://ncbi.nlm.nih.gov/pubmed/24530403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2014.01.096 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|